Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pneumonia 1Lung Neoplasms 1Lung Injury 1Hypoxia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 37Cytarabine 27Methotrexate 22Dexamethasone 20Vincristine 19fludarabine 15Mercaptopurine 14Etoposide 14Radiotherapy 12Daunorubicin 12Asparaginase 12Doxorubicin 11Prednisolone 9Idarubicin 9Busulfan 8pegaspargase 7blinatumomab 7Peripheral Blood Stem Cell Transplantation 6Melphalan 6Immunotherapy, Adoptive 6Imatinib Mesylate 6Dasatinib 6fludarabine phosphate 5Prednisone 5Methylprednisolone 5Filgrastim 5Whole-Body Irradiation 4Thioguanine 4Rituximab 4N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Thoracotomy × Clear all
NCT04755478 2021-02-16

OPEN THORUS

Hospital General Universitario de Valencia

Unknown
30 enrolled
LymphoidOther hematologic neoplasmThoracic

Hypoxia, Lung Neoplasms, Pneumonia, Postoperative Complications, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡